Reach Us +1-218-451-2974


Altered Phosphatidylcholine Metabolism In Alzheimer?s Disease Found Using UPLC-Q-ToF And NMR Based Metabolomics | 12515
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Altered phosphatidylcholine metabolism in Alzheimer?s disease found using UPLC-Q-ToF and NMR based metabolomics

International Conference on Psychology, Autism and Alzheimers Disease

Cristina Legido-Quigley

Accepted Abstracts: J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.004

Abberant lipid metabolism is implicated in Alzheimer?s disease (AD) pathophysiology, but the connections between AD and lipid metabolic pathways are not fully understood. To investigate plasma lipids in AD, a multiplatform screen (N=35 by LC-MS and N=35 by NMR) was developed which enabled the comprehensive analysis of plasma from three groups (AD, MCI and age matched control). This Metabolomics screen identified three phosphatidylcholine (PC) molecules that were significantly diminished in AD cases. In a subsequent validation study (N=141), PC variation in a bigger sample set was investigated. These three PCs were again significantly lower in AD cases: PC 16:0/20:5 (p<0.001), 16:0/22:6 (p<0.05) and 18:0/22:6 (p<0.01). A receiver operated characteristic (ROC) analysis of the PCs combined with ApoE data produced an area under the curve predictive value of 0.828. Confirmatory investigations into the background biochemistry indiciated no significant plasma change in three further PCs of similar structure, total choline containing compounds or three fatty acid side chains, adding to the evidence that specific PCs play a role in AD pathology.